Archive

  • SFCR 2025 - Lapse risk keeps pressure up on Italian lifers in 2024

    28 May 2025

    2023 may have been the peak of policyholders cashing in contracts early, but last year was not that much easier for Italian life insurers

  • Italy's lifers tackled lapse risk with action on investments in 2024

    28 May 2025

    SFCRs show range of ways life insurers sought to stem, or meet, surrenders last year

  • SFCR 2025 - French insurers win out from buying into alternatives in 2024

    22 May 2025

    Non-mainstream classes now make up to one-quarter of investment returns, some firms say

  • Axa's SFCR reveals details of €19bn in life policy surrender volumes for 2024

    20 May 2025

    Investment scenarios threaten French group's solvency the most, SFCR shows

  • Chart of the Week - European CFOs' ongoing appetite for private markets investments

    16 May 2025

    From infra to private credit and PE, CFOs' hunger shows little sign of abating

  • SFCRs 2025 - German lifers as Europe's hard-core 'non-core' investors

    08 May 2025

    Even after sleepy Bund yields staged a comeback, German life CIOs remain alive to rewards of alternative investments, their SFCRs show

  • Solvency of Zurich's German transfer insurer softens despite investment de-risking

    07 May 2025

    Zurich Legacy Life detailed its risk-taking in its latest SFCR

  • Axa's German life policy transfer unit saw market risk double in 2024

    06 May 2025

    But Ager Leben reduced its €1.6bn Zinszusatzreserve

  • Lloyd's syndicates ventured 'beyond the core' in 2024

    01 May 2025

    For most syndicates, 'core fixed income' was the anchor for their portfolios - but that did not prevent some from charting more distant waters with their general accounts in 2024

  • UK lifers unlock £78bn of capital benefits from MA in 2024

    01 May 2025

    Their benefit comprised £34.7bn lower SCRs and £43.4bn higher eligible own funds

Cookies on Insurance Asset Risk

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here